Table 1. Baseline characteristics of the CSA Leiden cohort and CSA Rotterdam cohort.
CSA Leiden (n = 433) |
CSA Rotterdam (n = 101) |
|
---|---|---|
Female sex, n (%) | 340 (79) | 78 (77) |
Age, mean (s.d.), years | 44 (13) | 45 (12) |
Symptom duration, median (IQR), weeks | 19 (10–48) | 19 (12–32) |
Positive squeeze test hand, n (%) | 177 (42) | 34 (34) |
Morning stiffness ≥60 min, n (%) | 65 (18) | 19 (22) |
Start of symptoms in small joints, n (%) | 391 (93) | 85 (93) |
TJC68, median (IQR) | 4 (2–9) | 3 (0–7) |
CRP, median (IQR) | 3.0 (1.9–4.1) | 3.0 (1.0–4.0) |
RF positive, n (%) | 81 (19) | 25 (26) |
ACPA positive, n (%) | 58 (14) | 25 (25) |
CSA: clinically suspect arthralgia; IQR: interquartile range; TJC68: tender joint count of 68 joints.